Elevance Health (ELV) received an 87% rating from Validea's Multi-Factor Investor model, based on Pim van Vliet's low-volatility strategy. This model targets low volatility stocks that also exhibit strong momentum and high net payout yields. As a large-cap growth stock in the Accident & Health Insurance sector, ELV's 87% score indicates significant interest from this quantitative strategy, which prioritizes conservative factor investing principles.
Elevance Health (ELV) has been flagged by a Validea quantitative model based on Pim van Vliet's low-risk, multi-factor strategy, achieving a high score of 87%. This model specifically seeks large-cap, low-volatility stocks that also possess strong momentum and high net payout yields. The positive rating is primarily driven by ELV's successful screening on low-risk attributes, as it passed the model's criteria for market capitalization and standard deviation. However, a deeper look at the model's components reveals a more nuanced picture. The stock received only a "Neutral" rating for both its "Twelve Minus One Momentum" and "Net Payout Yield." Consequently, despite the strong headline score, the stock received a "FAIL" on the strategy's "Final Rank", indicating that while it exhibits favorable low-volatility characteristics, it does not currently meet the momentum and yield criteria essential to this specific multi-factor approach.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.40
Ticker Sentiment
